Previous Close | 0.1000 |
Open | 0.1100 |
Bid | 0.0000 |
Ask | 2.1500 |
Strike | 110.00 |
Expire Date | 2024-05-31 |
Day's Range | 0.0500 - 0.1200 |
Contract Range | N/A |
Volume | |
Open Interest | 7 |
BURNABY, British Columbia, June 03, 2024--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet eligibility criteria now have coverage for Dexcom G6 and Dexcom G7 continuous glucose monitoring (CGM) systems.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tandem Diabetes' (TNDM) Mobi insulin pump is now compatible with Dexcom G7 CGM.